Blocking interleukin-4 enhances efficacy of vaccines for treatment of opioid abuse and prevention of opioid overdose

por Laudenbach, Megan, Baruffaldi, Federico, Robinson, Christine, Carter, Philipp, Seelig, Davis, Baehr, Carly, Pravetoni, Marco
Publicado 2018

Advancing humanized monoclonal antibody for counteracting fentanyl toxicity towards clinical development

por Hicks, Dustin, Baehr, Carly, Silva-Ortiz, Pedro, Khaimraj, Aaron, Luengas, Diego, Hamid, Fatima A., Pravetoni, Marco
Publicado 2022

Preclinical Efficacy and Selectivity of Vaccines Targeting Fentanyl, Alfentanil, Sufentanil, and Acetylfentanyl in Rats

por Baehr, Carly, Robinson, Christine, Kassick, Andrew, Jahan, Rajwana, Gradinati, Valeria, Averick, Saadyah E., Runyon, Scott P., Pravetoni, Marco
Publicado 2022

A trypanosome-derived immunotherapeutics platform elicits potent high-affinity antibodies, negating the effects of the synthetic opioid fentanyl

por Triller, Gianna, Vlachou, Evi P., Hashemi, Hamidreza, van Straaten, Monique, Zeelen, Johan P., Kelemen, Yosip, Baehr, Carly, Marker, Cheryl L., Ruf, Sandra, Svirina, Anna, Chandra, Monica, Urban, Katharina, Gkeka, Anastasia, Kruse, Sebastian, Baumann, Andreas, Miller, Aubry K., Bartel, Marc, Pravetoni, Marco, Stebbins, C. Erec, Papavasiliou, F. Nina, Verdi, Joseph P.
Publicado 2023